Intercept Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 20,524 | 0.0491% |
Individual Insiders | 1,108,937 | 2.65% |
General Public | 2,075,543 | 4.96% |
VC/PE Firms | 4,000,000 | 9.56% |
Institutions | 34,620,962 | 82.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
4,396,970 | €78.0m | 43.7% | no data | |||
4,180,224 | €74.2m | 36.9% | no data | |||
4,000,000 | €71.0m | 0% | no data | |||
2,077,893 | €36.9m | 0% | 1.13% | |||
2,071,222 | €36.7m | -55.9% | no data | |||
1,383,305 | €24.5m | 841% | no data | |||
1,293,510 | €22.9m | 0% | 10.98% | |||
1,199,066 | €21.3m | 0% | 0.31% | |||
1,161,401 | €20.6m | 192% | 0.02% | |||
955,005 | €16.9m | 37.5% | 0.01% | |||
941,755 | €16.7m | 8,020% | 0.75% | |||
896,294 | €15.9m | 0% | 10.78% | |||
879,400 | €15.6m | -16.3% | 0.03% | |||
861,801 | €15.3m | -6.67% | 0.1% | |||
777,402 | €13.8m | 5.7% | 0.06% | |||
667,979 | €11.9m | 17.2% | 0.02% | |||
640,688 | €11.4m | 0% | 3.94% | |||
618,894 | €11.0m | 0% | no data | |||
612,967 | €10.9m | 2.27% | no data | |||
601,322 | €10.7m | 0% | 2.38% | |||
591,333 | €10.5m | -13.4% | 0.01% | |||
472,847 | €8.4m | 7.28% | 0.03% | |||
432,746 | €7.7m | 0% | no data | |||
412,274 | €7.3m | 58.3% | 0.05% | |||
378,480 | €6.7m | 0% | 1.53% |